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Abstract.  Adhesive interactions  between neurons and 
extracellular matrix (ECM) play a key role in neuronal 
pattern formation.  The prominent role played by the 
extraceUular matrix protein tenascin/cytotactin in the 
development of the nervous system, tied to its abun- 
dance,  led us to speculate that brain may contain yet 
unidentified tenascin receptors.  Here we show that the 
neuronal cell adhesion molecule contactin/Fll,  a mem- 
ber of the immunoglobulin(Ig)-superfamily,  is a cell 
surface ligand for tenascin in the nervous system. 
Through affinity chromatography of membrane gly- 
coproteins from chick brain on tenascin-Sepharose, 
we isolated a major cell surface ligand of 135 kD 
which we identified as contactin/Fll  by NH2-terminal 
sequencing.  The binding specificity between contactin/ 
Fll  and tenascin was demonstrated in solid-phase as- 
says.  Binding of immunopurified  125I-labeled contac- 
tin/Fll  to immobilized tenascin is completely inhibited 
by the addition of soluble tenascin or contactin/F11, 
but not by fibronectin.  When the fractionated isoforms 
of tenascin were used as substrates,  contactin/Fll 
bound preferentially to the 190-kD isoform. This iso- 
form differs in having no alternatively spliced fibro- 
nectin type [] domains.  Our results imply that the in- 
troduction of these additional domains in some way 
disrupts the coutactin/Fll  binding site on tenascin. 
To localize the binding site on contacrin/Fll,  proteo- 
lyric fragments were generated and characterized by 
NH2-terminal sequencing.  The smallest contactin/F11 
fragment which binds tenascin is 45 kD and also be- 
gins with the contactin/Fll  NH2-terminal sequence. 
This implies that contactin/Fll  binds to tenascin 
through a  site within the first three Ig-domains. 
M 
OLECULES of the extracellular  matrix  have  been 
implicated  to play a pivotal role in tissue morpho- 
genesis. Tenascin (also known as cytotactin, hexa- 
brachion, J1-220) is a large multidomain extracellular  matrix 
(ECM) t glycoprotein that shows a highly restricted expres- 
sion pattern in developing  embryos (reviewed by Erickson 
and Bourdon,  1989).  In rotary-shadowed  electron micro- 
graphs,  tenascin appears as a hexabrachion  consisting of six 
individual polypeptide chains joined via their amino termini 
(Erickson and Iglesias,  1984; Vaughan et ai.,  1987).  Each 
polypeptide chain  is composed of tandemly connected do- 
mains,  either homologous to EGF or to the type Ill repeats 
of fibronectin  or to fibrinogen  (see Fig.  4 A) (Jones et al., 
1989, Spring et al.,  1989).  Structural  variation  is provided 
by alternative  splicing within the fibronectin type III homol- 
ogy region (see Fig. 4 A). In the chick, up to three additional 
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domains  are incorporated,  giving  rise  to isoforms which 
range in size from 190 kD, with no additional  domains,  to 
220 kD with three extra domains (Spring et al., 1989; Jones 
et al.,  1989). The site for alternative  splicing, between do- 
mains five and nine,  is conserved between species, but the 
number of additional  domains differs, with mouse tenascin 
having up to five (Weller et ai.,  1991) and human tenascin 
up to seven extra type [] repeats (Gulcber et al., 1989). This 
variation  appears to be under tight cellular control as only 
homobexamers have been isolated  from either cell cultures 
(Kaplony et al., 1991; Chiquet et al., 1991) or tissue extracts 
(Kaplony et al., 1991). The spatial and temporal expression 
of tenascin isoforms during development is also tightly regu- 
lated (Aufderbeide et al., 1988; Matsuoka et al., 1990; Kap- 
lony et al.,  1991). 
The functional  role(s)  of the alternatively  spliced forms 
may be established,  in part,  through  the identification  of 
isoform-specific  ligands.  Tenascin  has  been  reported  to 
mediate contrary functions:  a tenascin substratum can be ei- 
ther repulsive or adhesive for cells,  with the EGF-repeats 
mediating  the former and the type [] region, including  the 
alternatively  spliced domains, the latter effect (Spring et al., 
1989). Little is known, however, about the cellular receptors 
interacting  with  these domains.  Until  now a  Bt-integrin, 
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lahti, 1989), and two different proteoglycans, the membrane 
bound syndecan (Salmivirta et al., 1991) and an extracellular 
matrix chondroitin sulfate proteoglycan, the cytotactin  bind- 
ing proteoglycan (Hoffman and Edelman, 1987),  have been 
proposed as tenascin ligands, yet their binding sites on tenas- 
tin remain obscure. 
In the nervous system, the distribution of tenascin is cor- 
related with key developmental processes such as cell migra- 
tion,  axonal  outgrowth,  and  tissue  boundary  formation 
(reviewed by Chiquet, 1989; see also Edelman and Crossin, 
1991; Reichardt and Tomaselli,  1991). Tenascin is synthe- 
sized by glial cells of the central and peripheral nervous sys- 
tem (CNS and PNS, respectively), and in the PNS by mesen- 
chymal cells that are in contact with developing neurons 
(Wehrle and Chiquet, 1990;  Crossin et al.,  1986;  Chuong 
et al., 1987; Prieto et al., 1990).  For instance, during gran- 
ule cell migration in the cerebral cortex, the expression of 
tenascin on the Bergman glia coincides with the migration 
of the granule neurons along the glial processes (Chuong et 
al., 1987). Direct evidence for a role of tenascin in neuronal 
migration was obtained by blocking granule cell migration 
within the  molecular layer in  cerebellar  explant cultures 
(Chuong et al.,  1987; Husmann et al.,  1992).  A  role for 
tenascin in migration of the neural crest is implicated from 
its distribution along the paths of cranial neural crest cells 
(Bronner-Fraser, 1988; Kaplony et al., 1991) and its expres- 
sion in the rostral sclerotome of the trunk (Tan et al., 1987; 
Mackie et al.,  1988).  As neural crest cells migrate exclu- 
sively  through  the  rostral  portion  of  the  sclerotome 
(presumptive vertebrae) and avoid the caudal half, this pat- 
tern correlates with their metameric migration pattern giv- 
ing rise to the segmental organization of the PNS (Keynes 
and Stern, 1988). It is debated, however, if tenascin is pres- 
ent in the rostral sclerotome before the entry of the neural 
crest (Tan et al., 1987; Mackie et al., 1988) or accumulates 
in this region in response to neural crest immigration (Stern 
et al.,  1989).  Certainly, tenascin is available  as a substrate 
for motor axons that emerge from the ventral neural tube 
several hours after neural crest cells and similarly project ex- 
clusively across the rostral sclerotome region (Keynes and 
Stern,  1984;  Wehrle and Chiquet,  1990).  In vitro studies 
using  spinal  cord  explants  showed  that  motor  axons 
efficiently  grow on plain tenascin substrata (Wehrle and Chi- 
quet, 1990). Studies in different  laboratories have shown that 
tenascin promotes the growth of neurites from both CNS and 
PNS neurons. Provided the cell bodies are attached through 
polyamines,  the  growth  cones  of the  extending  neurites 
efficiently attach and are highly motile on a tenascin substra- 
tum, although their morphology differs from growth cones 
extending on highly permissive substrata such as laminin 
(Wehrle and Chiquet, 1990; Lochter et al., 1991). Together 
with the observation that neurites avoid tenascin substrata if 
given a choice between tenascin and other ECM substrata 
such as fibronectin (Faissner and Kruse,  1990),  it appears 
that tenascin is able to modulate adhesive interactions be- 
tween developing axons and their surroundings and thus con- 
tribute to the establishment of neuronal circuitry. 
Despite this evidence for a role in nervous system organi- 
zation,  so far only one neuronal ligand for tenascin,  the 
cytotactin-binding proteoglycan, has been reported (Hoff- 
man and Edelman, 1987). A number of cell adhesion mole- 
cules (CAMs) with restricted neuronal expression have been 
identified (Jessell, 1988; Rutishauser and Jessell, 1988), and 
evidence is gathering for them having prominent roles in the 
establishment of neuronal networks. Sequence analysis of 
these proteins showed that many neural cell adhesion mole- 
cules (N-CAM)  are members of larger gene families (for 
reviews see Edelman and Crossin, 1991; Rathjen and Jessell, 
1991). A prominent family of CAMs is the immunoglobulin 
superfamily that includes the N-CAM (Cunningham et al., 
1987), neuron-glia cell adhesion molecule (Ng-CAM) (Bur- 
goon et al.,  1991), L1 (Moos et al.,  1988),  TAG-1 (Furley 
et al., 1990),  axonin-1 (Stoeckli et al., 1991), chick contac- 
tin/Fll (Ranscht, 1988; Briimmendorf et al., 1989) and its 
mouse homologue F3 (Gennarini et al., 1989). These mole- 
cules have been shown to bind to other members within this 
family by homophilic (Lemmon et al., 1989) or heterophilic 
interactions (Knlm et al., 1991). The chick extracellular ma- 
trix  protein  restriction  (Rathjen  et  al.,  1991) has  been 
copurified with contactin/Fl  1,  indicating that extracellular 
matrix  components  could  act  as  additional  heterophilic 
ligands for this class of CAMs. 
In the present study we describe the identification of the 
neuronal glycoprotein contactin/F11 as a tenascin receptor. 
We present evidence for the binding between the fibronectin 
type III homology region of tenascin and a site within the 
three distal immunoglobulin-like repeats of contactin/F11. 
The interaction between these domains may not only be rele- 
vant for neuron-glia interactions, but constitute a  general 
mechanism to  regulate cell-cell  and cell-matrix interac- 
tions. 
Materials and Methods 
Antibodies 
The mouse monoclonal IgG antibodies I"16 and I"17 against chicken tenas- 
cin have been described (Kaplony et al., 1991). mAb 4D1 is specific for con- 
tactin/F11  (Ranschi et  ai.,  1984).  Antibodies T16,  TI7,  and 4D1  were 
purified  from  ascites  fluid  by  affinity  chromatography  on  protein 
A-Sepharose CL 413 (Pharmacia, Uppsala, Sweden). mAb affinity columns 
were prepared by coupling of isolated IgG to CNBr-activated Sepharose 4B 
(Pharmacia) to a final concentration of 2 nag IgG per ml resin. 
ECM Molecules 
Chicken embryonic fibroblast tenascin (CEF-Tn)  was purified from condi- 
tioned culture media of primary chicken embryo fibroblasts, grown in bulk 
cytodex microcarrier cultures (Pharmacia) by affinity chromatography on 
a T16-Sepharose column (Kaplony et al., 1991). The purity of the isolated 
tenascin was judged by  SDS-PAGE.  For  the preparation of the tenas- 
cin-Sepharose affinity column,  CEF-Tn was coupled to CNBr-acfivated 
Sepharose 413 (Pharmacia) to a final concentration of 5 mg/ml resin. Critical 
for the preparation of such an affinity column was the isolation of tenascin 
in  a  concentrated,  soluble  form  from  fibroblast conditioned medium. 
Through the use of microcarrier cultures, a high cell/volume ratio is ob- 
tained in the culture medium, of which batches of 10-20 liters were then 
concentrated 10-fold by ultrafiltration, using a  100-kD cut-off, tangential 
flow filter. This medium concentrate was then used for the affinity purifica- 
tion of  tenascin on a mAb T16-column. 15-20 nag CEF-Tn were isolated per 
batch. Four batches were used for the setup of a high capacity CEF-Tn-col- 
unto. Coupling of CEF-Tn to CNBr-activated Sepharose 413 was performed 
following the manufacturer's instructions with CEF-Tn in 0.1 M NaI-ICO3, 
0.5 M NaCI, pH 8.3, as coupling solution. Coupling was performed on a 
stirring wheel for 2 h and the efficiency of the coupling step (between 70 
and 80% of tenascin were coupled) was determined by photometrical mea- 
surement of the concentration of uncoupled tenascin at 280 urn. 
Chick brain tenascin was purified from 17-d-old embryonic chick brain 
by immunoaffinity chromatography. In a typical experiment, 100 g chick 
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buffer A (20 mM Tris, 1 mM CaCl2,  1 mM MgCI2, 1 mM PMSE 25 mM 
6-aminocaproic acid, 4 #g/ml leupeptin, 4/~g/ml pepstatin, 0.02 % NAN3) 
and extracted overnight at 4~  The extract was  centrifuged for 2  h  at 
15,000 g. The supernatant was diluted with 4 vols buffer A and used as 
source of tenascin, while the pellet was used for the isolation of putative 
tenascin receptors. The supernatant was passed sequentially over a gelatine- 
Sepharose 4B column (to remove fibronectin) and a T16-Sepharose column. 
To  remove unspecifically  bound material,  the T16  affinity  column was 
washed with 0.1% Triton X-100, 0.5 M NaCI in buffer A and extensively 
washed with 0.15 M NaCI in buffer A in a subsequent step. Bound material 
was eluted with 0.1 M  triethylamine buffer,  pH  11.5, containing 0.15 M 
NaC1, 1 mM CaC12, 1 mM MgCI2, 1 mM PMSF, and 0.02% NAN3. Frac- 
tions were immediately neutralized with 1 M Tris, pH 5.8, and analyzed on 
SDS-PAGE. The peak fractions were frozen at -18~  A typical yield was 
4-5 rng tenascin per 100 g chick brain. 
Isoforms  of  chick  brain  tenascin  were  isolated  using  serial  im- 
munoaflinity chromatography (Kaplony et ai., 1991). The supernatant, pre- 
pared as described in the above isolation procedure, was passed sequentially 
over a gelatine-Sepharose 4B column, followed by T17-Sepharose (to retain 
tn 220) and T16-Sepharose  (to retain the remaining isoforms).  After load- 
ing, the antibody columns were washed and eluted separately,  as described 
above. 
Fibronectin was isolated from chicken blood according to Ruoslahti  et 
al. (1982). For the preparation of the affinity column, fibronectin was cou- 
pled to CNBr-activated Sepharose 4B to a final concentration of 2 mg/ml 
resin. 
Mouse laminin was purchased from Collaborative Research, Inc. (Lex- 
ington, MA). 
Ajfinity Chromatography 
El7 chick brains were homogenized in 1 M  NaCI in buffer B  (20 mM 
Tris, 2 mM CaCI2, 2 mM MgC12, 1 mM MnCI2, 2 mM PMSE 25 mM 
6-aminocaproic acid, 4/zg/rnl leupeptin, 4/tg/lnl pepstatin, 0.02% NAN3, 
pH 7.5) and extracted overnight at 4~  The extract was centrifuged for 2 h 
at 15,000 g. The pellet was again homogenized, but now in a 5-10-fold vol 
of buffer B containing 150 mM 1-octylglucoside (BOG) (Sigma Chemical 
Co., Deisenhofen, BRD) and 150 mM NaCI and extracted overnight at 4~ 
The extract was centrifuged at 100,000 g for 1 h at 4~  the supernatant 
was passed over a wheat germ agglutinin (WGA)-Sepharose  column (Phar- 
macia) and a membrane-glycoprotein  fraction was ehited with 10% (wt/voi) 
N-acetyl-D-glucosamine,  30 mM BOG, and 50 mM NaC1 in buffer B. The 
WGA-fraction was first passed over a Sepharose 413 precolumn (Pharmacia) 
and then over tenascin-Sepharose 4B. The columns were washed exten- 
sively with 30 mM BOG, 50 mM NaCI in buffer B, and eluted separately 
with a NaCl-gradient (0.05-0.4 M NaCI, 30 mM/~OG in buffer B). Aliquots 
of the elnate from the tenascin-column were precipitated with 30% trichlo- 
roacetic acid, run in a SDS-PAGE 5-10% gradient-gel  under nonreducing 
conditions, and either fixed and silverstained or blotted onto a polyvinyli- 
dene difluoride (PVDF)-membrane (Immobilon; Millipore Corp.,  Bed- 
ford, MA). 
Affinity chromatography with fragments of contactin/Fl  I was performed 
in the  following  manner:  ~25I-labeled fragments of comactin/Fll  were 
added to binding buffer G, and applied to a Sepharose-4B  precolumn fol- 
lowed by a tenascin-Sepharose column in series. After loading, the columns 
were disconnected and extensively washed with binding buffer; the columns 
were subsequently eluted with 0.5 M NaCI, 2 mM CaC12, 2 mM MgCI2 
in buffer C (20 mM Tris, 0.02% Triton X-100, 1 mM PMSF, pH 7.5), then 
with 10 mM EDTA in buffer C, and finally with 1.5 M NaCI in buffer C. 
Fractions were collected and radioactivity measured. As a control, the same 
procedure was performed on a fibronectin-Sepharose  4B column. Aliquots 
of each fraction were analyzed by autoradiography after 8-15 % SDS-PAGE. 
Immunopurification of Contactin/Fll 
Contaetin/Fll was isolated from either detergent-containing or detergent- 
free E 17 chick brain extracts by lectin- and immunoaffinity  chromatogra- 
phy. Detergent-free chick brain extract was prepared as described above for 
the isolation of tenascin. Chick brains were homogenized with 1 M NaC1 
in ice-cold buffer A and extracted overnight at 4~  The extract was cen- 
trifuged for 2 h at 15,000 g. Both the supernatant and the pellet were used 
as source of contactin/Fl  1. For the isolation of detergent-free contactin/F11, 
the superuntant was diluted with 4 vol of buffer A and passed over a WGA- 
column. A glycoprotein fraction was elnted with 10% N-acetyl-D-glucos- 
amine in buffer containing 20 mM Tris, 0.2 M NaCI, 1 mM CaC12, 1 mM 
PMSE pH 7.5.  The eluate  was subsequently  loaded  onto  the  mAb 4DI- 
column. Bound material was eluted with 0.1 M triethylamine buffer, pH 
11.5, with 0.15 M NaCl, 1 mM PMSE Fractions were neutralized immedi- 
ately by addition of 1 M Tris buffer, pH 5.8. 
Detergent extracts of contactin/Fll were obtained by overnight extrac- 
tion of the pellet with 150 mM lOG in buffer A containing 0.2 M NaCI 
at 4~  The extract was centrifuged at 100,000 g for 1 h at 4~  the superna- 
tant  was  passed  over  a  WGA-Sepharose  column  and  a  membrane- 
glycoprotein fraction was ehited with 10% (wt/vol) N-acetyl-D-glucosamine 
in buffer D (30 mM BOG, 20 mM Tris, 0.2 M NaC1, 1 mM CaCI2, 1 mM 
PMSF, pH 7.5). The ehiate was applied onto the mAb 4D1 column. After 
extensive washing  with buffer D, bound material was eluted with 0.1 M 
triethylamine buffer,  pH  11.5, with 30 mM lOG, 0.15 M  NaC1,  1 mM 
PMSE  Fractions were neutralized immediately by addition of 1 M  Tris 
buffer, pH 5.8. 
Radiolabeling 
Proteins  were  radiolabeled  with  125-iodine  (Amersham  International, 
Amersham, UK) by use of the Enzymobead method (BioRad Laboratories, 
Richmond, CA), following the manufacturer's instructions. 
Fragmentation of Contactin/F11 
Collagenase (EC 3.4.24.3,  SERVA) was added to a final concentration of 
0.6 U/ml to 300 pg immunopurified soluble contactin/H1 in 20 mM Tris, 
150 mM NaCI,  10 mM CaC12, 1 mM PMSE pH 7.5, incubated for 4 h at 
37~  and stopped by addition of EDTA. The contactin/F11  fragments were 
immediately freed of collagenase by binding to a WGA-cohimn. Fragments 
were eluted from the WGA-column with 10% N-acetylglucosamine  in 20 
mM Tris,  150 mM NaC1, 0.02% Triton X-100, 1 mM PMSE pH 7.5. Ali- 
quots of the eluate were analyzed by silverstaining or by autoradiography 
after labeling with 125-iodine by the Enzymobead method on SDS-PAGE. 
Solid Phase  Assay 
Removable  96-well  microtiter plates (Maxi Sorp; Nunc, Roskilde,  Den- 
mark) were coated with 20/~g protein/ml in buffer E (20 mM Tris, 50 mM 
NaCI, 2 mM CaC12, 2 mid MgC12, 0.02% NAN3, pH 7.5) in a 100 t~l vol 
per well and incubated overnight at 24~  Negative  controls received the 
same treatment with 0.1% heat-denatured (hd) BSA in buffer E. After incu- 
bation, the wells were washed three times with washing buffer F (0.02 % 
Tween 20, 20 mM Tris,  50 mM NaCI, 0.02%  NAN3, pH 7.5) and unused 
binding sites blocked by addition of 0.2 ml of 0.1% hd BSA in buffer E for 
2 h at 24~  After blocking, wells were washed three times with buffer E 
To allow complete saturation with Ca2+/Mg  2+, wells were incubated with 
buffer E for 30 rain at 24~  Then constant amounts (100,000 cpm) of 125I- 
labeled contactin/Fl  1 (see Fig.  1, lane 4) in binding-buffer  G (0.02% Triton 
X-100, 20 mM Tris, 50 mM NaCI, 2 mM CaC12, 2 mM MgCI2, 0.02% 
NAN3, pH 7.5) were added to the wells and incubated for 2 h at 37~  In 
our standard assay conditions, the salt concentration of the binding buffer 
was 50 mM NaC1, however similar results were obtained using a salt con- 
centration of 150 mM NaC1. For the inhibition studies,  125I-labeled con- 
tactin/F11  was incubated in a 100/~1 vol of different dilutions of tenascin, 
fibronectin, contactin/Fll, and BSA in buffer G. After incubation, the wells 
were washed four times with 0.2 ml of washing buffer E  and counted for 
bound activity. Specific binding was determined as total minus nonspecific 
binding. Nonspecific  binding was  determined on BSA.  Binding of 125I- 
labeled contactin/Fl  1 to immobilized tenascin in the absence of competing 
soluble proteins was taken as 100%. In some cases bound radiolabel was 
extracted with sample buffer for SDS-PAGE, run on a 5-10% SDS-PAGE 
gradient gel, and autoradiographed. 
Gel Electrophoresis, lmmunoblotting, 
NHrterminal Sequencing 
SDS-PAGE was carried out as described by Laemmli (1970) and gels were 
stained with silver as described by Nielsen and Brown 0984). Immunoblot- 
ring was performed in the following way: proteins electrophoresed in SDS- 
PAGE were transferred to nitrocellulose (BA 85; Schleicher & Schull, Das- 
sel, Denmark) using a semidry blotting chamber system (Sartorius Corp., 
G6ttingen, Denmark) according to the instructions of the manufacturer.  The 
nitrocellulose was  incubated with mAb,  followed  by alkaline phospha- 
tase-conjugated goat anti-mouse IgG Ohgo,  Inc., Buflingame,  CA), and 
stained with 5-bromo-4-chloro-3-indonyl-phosphate  and nitroblue tetraz~o- 
lium (Sigma Chemical Co., St. Louis).  For NHe-terminal sequencing,  pro- 
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(Imrnobilon, Millipore  Corp.). Ponceau  S (Serva  Biochemicals,  Paramus, 
NJ) stained bands were cut out and sequenced  through their NH2-termini 
with an Applied  Biosystems  470 A sequencer  and a 120 A phenylthiohydan- 
toin-derivative  analyzer. 
Results 
Contactin/Fll Binds to the Tenascin-AJ~nity Column 
Tenascin is expressed at high levels in the developing brain 
and is implicated to play an important role in establishing 
neural patterns (Steindler et al.,  1989; Crossin et al., 1989; 
Bartsch et al.,  1992). In brains of 17-d-old chick embryos, 
two of the major tenascin isoforms, the 220-kD isoform (tn 
220) and the 190-kD isoform (tn 190) can be detected in high 
amounts (Kaplony et al.,  1991). For these reasons, we pre- 
pared a membrane glycoprotein fraction from chick brain of 
this embryonic stage to search for putative tenascin recep- 
tors. To exclude extracellular matrix (EMC)- and cytoplas- 
mic proteins from our receptor preparations,  brains were 
homogenized and extracted in detergent-free buffer, contain- 
ing 1 M NaCI. With this approach most, if not all, tenascin 
could be removed from the tissue, indicating that this extrac- 
tion is highly efficient for ECM components. Insoluble pro- 
teins were collected by centrifugation and the membrane- 
rich pellet extracted in detergent- (150 mM BOG) containing 
buffer.  Detergent-soluble  proteins  were  used  as  a  crude 
membrane fraction and enriched for membrane glycopro- 
teins through lectin-affinity chromatography on WGA-Seph- 
arose (Fig.  1, lane/). To isolate putative tenascin receptors 
in this fraction, the WGA-binding glycoproteins were passed 
over a tenascin-Sepharose affinity column. As interactions 
between ECM  molecules and their cellular receptors are 
generally of low affinity, a tenascin-affinity column of extra 
high  capacity was  used.  In  total,  >50  mg  chick embryo 
fibroblast  (CEF)-tenascin  were  coupled  to  10  ml  CNBr- 
activated Sepharose 4B. The possibility of  non-specific bind- 
ing was eliminated by passing the WGA-binding glycopro- 
teins through a Sepharose 4B precolurnn before the tenascin 
column. No proteins were detected binding to this precol- 
Figure L Identification ofcon- 
tactin/Fl 1 as the main cellular 
ligand of tenascin in detergent 
extracts from chick embryonic 
brain by affinity chromatogra- 
phy  on  tenascin-Sepharose. 
Fractions were analyzed after 
SDS-PAGE on gradient  gels 
by either silver staining (lanes 
1-3) or autoradiography after 
125I labeling (lane 4). (lane 1) 
Detergent extract from day 17 
(El  7) chicken embryonic brain 
before affinity purification on 
tenascin-Sepharose;  (lane 2) 
fraction  eluted  with  a  NaCI 
gradient from the tenascin column. The prominent band at 135 kD 
was subjected to NH2-terminal sequencing and found to be iden- 
tical to residues 2-18 (see text) of contactin/Fll; (lane 3) contac- 
tin/Fl 1 isolated through immunoaffinity chromatography on mAb 
4D1-Sepharose; and (lane 4) ~25I-labeled  immunopurified contac- 
tin/F11 used in solid-phase binding assays. 
l~gure 2.  Affinity chromatography  on tenascin-Sepharose.  (A) 
Chick brain (E 17) membrane glycoprotein eluate from  WGA-Seph- 
arose, prior loading onto the tenascin-column Oane 1), and in the 
flow-through  after the tenascin column (lane 2), run on SDS-PAGE 
and detected by silver staining. The prominent band in the eluate 
of the tenascin column (lane 3), which was identified as contactin/ 
Fll, contributes to the broad band at 135 kD. (B) Binding of con- 
tactin/Fll to the tenascin column was efficient. Flow-throughs of 
three independent experiments were subjected to SDS-PAGE, and 
electrotransferred to nitrocellulose. For immunodetection of con- 
tactin/Fll, the nitroeellniose was incubated with mAb 4D1. For 
visualization, an alkaline phosphatase-conjugated secondary anti- 
body was used.  Immunostaining shows a complete depletion of 
contactin/F11 in the first two experiments (lanes 1 and 2). In the 
third, where double the mount of membrane glycoprotein extract 
was applied to the tenascin column,  the flow-through now con- 
tained some contactin/Fll (lane 3). 
urnn. The major ligand in chick brain detergent extracts re- 
tained on the tenascin column was eluted with a NaC1 gra- 
dient and migrated as a protein of 135 kD on SDS-PAGE 
(Fig.  1, lane 2). It was identified as contactin/F11 (Ranscht 
et al.,  1988;  Briimmendorf et al.,  1989) by NH2-terminal 
sequencing which gave the following sequence: XHFSEE- 
GNKGYGPVFEEQ (single letter code, X stands for a non- 
identified amino acid). None of the known tenascin-binding 
proteins in brain such as the cytotactin-binding proteoglycan 
(Hoffman and Edelman,  1987) or restrictin (Rathjen et al., 
1991) was detected in this fraction. As both the cytotactin- 
binding proteoglycan and restrictin are extracellular matrix 
proteins and can be extracted without detergents (Hoffman 
and Edelman, 1987; Rathjen et al., 1991), it seems likely that 
they were solubilized along with tenascin in the 1.0 M NaCI 
extract and were therefore not present in the membrane prep- 
aration applied to the tenasein-affinity column. 
A further indication of the specificity of the tenascin-con- 
tactin/F11 interaction comes from experiments showing that 
contactin/F11 is depleted in the flow-throughs of the tenas- 
cin-Sepharose column, Dominant in silver-stained gels of 
the membrane glycoprotein fraction (Fig. 2 A, lane/) ap- 
plied to the tenascin column is a broad band of 135 kD. Al- 
though the staining intensity of  this band is diminished in the 
flow-through of the tenascin column (Fig. 2 A, lane 2), con- 
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2 B), suggesting that other proteins of identical molecular 
mass contribute to this band. This can be seen in Fig. 2 B, 
where aliquots from the flow-throughs of three independent 
experiments were tested with the contactin/F11 specific mAb 
4D1 (Ranscht et al., 1984) after immunoblotting and separa- 
tion on SDS-PAGE (Fig. 2 B). In each of  the first two experi- 
ments, the complete eluate from a 20-ml WGA-Sepharose 
colunm was applied to the tenascin-Sepharose. In the third, 
two  such eluates were combined before loading onto the 
tenascin column. Contactin/F11 was removed to completion 
from each of the first two WGA eluates, however, not all con- 
tactin/Fll  was removed when the amount loaded onto the 
tenascin column was doubled, as can be seen in Fig. 2 B, lane 
3. These results show that providing the capacity of  the tenas- 
cin column is not exceeded, contactin/F11 can be efficiently 
and selectively depleted from extracts containing a complex 
mixture of membrane glycoproteins. 
Binding of Contactin/F11 to Immobilized Tenascin 
To determine directly the binding specificity between con- 
tactin/Fll  and  tenascin,  we  used  a  solid-phase  assay  on 
different substratum-bound molecules, including immuno- 
purified contactin/Fll.  Microtiter wells were coated with 
either chick brain tenascin or chick fibronectin or chick con- 
tactin/F11, or mouse laminin. Contactin/Fl 1 (Fig. 1, lane 3), 
used for the coating of wells, was isolated from detergent- 
free extracts of embryonic chick brain through lectin-affinity 
chromatography  on  WGA-Sepharose and  immunoaffinity 
chromatography on the  contactin/Fll  specific mAb  4D1- 
column. Wells, coated with the mAb 41)1 served as positive 
controls for maximal binding and wells coated with 0.1% hd 
BSA as negative controls in this assay. Binding studies were 
carried out using ~25I-labeled immunopurified contactin/F11 
(Fig.  1,  lane  4),  isolated  from  either  detergent-free  or 
detergent-containing extracts of chick brain as described in 
Materials and Methods. No difference in the electrophoretic 
mobility in SDS-PAGE could be detected between contac- 
tin/HI from these two sources. Wells were incubated with 
125I-labeled contactin/Fll  for  2  h  at  37~  washed,  and 
counted for bound  radioactivity.  The absolute  amount of 
bound radioactivity varied between assays, but the ratio of 
binding between contactin/Fll  and  various  substrates  re- 
mained constant. As a consequence, the binding values for 
contactin/Fll  are expressed as  100%  relative to tenascin 
with the binding to the negative control, BSA, set as 0%. In 
comparison,  five times more contactin/Fll binds to wells 
coated with  the  contactin/Fll  specific mAb  4D1  than to 
tenascin (data not shown),  reflecting the value for a  high 
affinity binding and the maximum possible in this assay. As- 
suming tenascin and IgG (4D1) coat with similar efficiencies, 
and that each possesses one binding site per monomer of 190 
and 75 kD, respectively, then the binding of contactin/Fll 
per mole of coated substratum compares very favorably. All 
values were means of at least triplicate determinations and 
their standard deviations were <10 %, apart for that of bind- 
ing to laminin which was 14%. The differences of the means 
were  compared statistically  using  t  test.  Binding  of lz~I- 
labeled contactin/F11 to chick brain tenascin was 4-5 times 
higher than to the negative control, BSA, alone (p <  0.001) 
(Fig.  3).  The binding between contactin/Fll  and tenascin 
was also significantly higher than the binding to all the other 
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Figure 3.  Binding of ~25I-la- 
beled contactin/F11 to various 
substrates was tested in a solid 
phase assay (see Materials and 
Methods).  Binding of 125I-la- 
beled eontaain/F11 to tenascin 
(Tn, chick brain tenascin, con- 
taining all isoforms) was sig- 
nificantly  higher  compared 
with binding to contactin/F11 
(Cont)  or  chick  fibroneetin 
(Fn) or mouse laminin (Ln). 
Nonspecific  binding was deter- 
mined on BSA. Specific bind- 
ing  was  determined  as  total 
minus  nonspecific  binding. 
Binding  activity  is  plotted 
the tenascin substrate, which 
was 4-5 times higher than binding to the negative control,  BSA 
alone. All values are means of at least triplicate determinations. 
Standard deviations were <10%,  other than for laminin where it 
was 14%. 
substrates tested (p <0.01). The homophilic binding to itself 
was significantly higher compared with heterophilic binding 
to laminin or fibronectin (19 <  0.01), and all were significant 
when compared with binding to BSA (p <  0.01). 
The binding between contactin/Fll and tenascin was di- 
rectly demonstrated in competitive binding  studies,  again 
using  125I-labeled contactin/Fll  in  the  solid  phase  assay. 
Microtiter wells, coated with chick brain tenascin, were in- 
cubated with  '25I-labeled  contactin/Fll  in the presence of 
different concentrations of competing soluble proteins. The 
specificity of the binding between chick brain tenascin and 
contactin/Fll  is  demonstrated in  Fig.  4.  Binding  of ~25I- 
labeled contactin/F11 to immobilized tenascin was inhibited 
to completion (i.e., to background values) in a dose-depen- 
dent manner by tenascin in solution (Fig. 4 A), while the ad- 
dition of soluble chicken fibronectin (Fig. 4 C) or BSA (Fig. 
4  D)  had only marginal effects. Moreover, the binding of 
~25I-labeled contactin/Fll to immobilized tenascin was also 
quantitatively blocked by the addition of unlabeled soluble 
contactin/Fll (Fig. 4 B). These results demonstrate a spe- 
cific interaction between contactin/F11 and tenascin. 
Contactin/Fll Binds Preferentially to the tn 190 
Isoform of Tenascin 
A demanding test in the work with a protein-like tenascin, 
which exists in several isoforms, is to establish whether the 
property being examined is isoform specific. The homohexa- 
meric (or homotrimeric) chick tenascin exists in at least 
three different variants, generated by alternative splicing of 
fibronecfin type III homology domains (Fig. 5 A). Relative 
to tn 190, tn 200 contains one and tn 220 three additional 
type Ill domains (Spring et al.,  1989; Jones et al.,  1989). 
The major isoforms in 17-d chick embryo brain are tn 190 
and 220, while tn 200 is less abundant (Fig. 5 B, lane 2). 
Serial affinity chromatography (Kaplony et al., 1991) on T17- 
Sepharose (to isolate tn 220) and T16-Sepharose (to retain 
the remaining tn 190) permitted separation of tn 220 from 
tn 190, the latter containing minute amounts of tn 200 (Fig. 
5 B). Binding tests of l~I-labeled contactin/Fll to the im- 
mobilized isoforms indicated that contactin/Fll clearly fa- 
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Figure 4. Competition-assays: binding of |25I-labeled contactin/F11 to immobilized chick brain tenascin was completely inhibited through 
addition of unlabeled soluble tenascin (A) or contactin/Fll (B) in solid-phase assays (described in Materials and Methods). In comparison, 
little or no inhibition through addition of fibronectin (C) or BSA (D) was observed. 
Figure 5. Chick tenascin exists in at least three different isoforms generated by alternative splicing. (A) Structural model of these isoforms. 
(B) Tenascin and its isoforms detected by silver staining after running on SDS-PAGE under reducing conditions. CEF-tn chicken embryo 
fibroblast tenascin (lane 1); chbr-tn,  chicken brain tenascin, containing all three isoforms (lane 2); m 190,  190-kD isoform of tenascin, 
containing minute amounts of the 200-kD isoform (lane 3); and tn 220,  220-kD isoform (lane 4). 
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tn 190 or tn 220 or to the unfractioned isoforms, Tn. Extraction of 
bound radiolabel (B) from wells coated with tn 190 (lane 1) in com- 
parison to tn 220 (lane 2). No binding to BSA was observed (lane 
3). Tenascin isoforrns were coated at a concentration of 20 t~g/ml 
in a pH 7.5 buffer containing 20 mM Tris, 50 mM NaCl, 2 mM 
CaCl2, 2 mM MgC12, 0.02% NAN3, and control wells were coated 
with 0.1% heat denatured BSA. After washing, blocking, and sat- 
uration with Ca2+/Mg  2+, wells were incubated with equal amounts 
of ~25I-labeled  contactin (100900 cpm/well) for 2 h at 37~  After 
extensive washing, wells were extracted with sample buffer for 
SDS-PAGE, run on a 5-10% gradient gel, and autoradiographed. 
vored binding to the tn 190 fraction. The binding values to 
tn 190 were identical to values of binding between contac- 
tin/F11 and unfractioned chick brain tenascin (Tn), and were 
significantly higher than the binding to tn 220 (p <  0.001) 
(Fig.  6  A).  Binding  to  tn  220,  although  low,  was  still 
significant when compared with binding to BSA (p =  0.01). 
The differences between tn  190 and 220 were not artefacts 
due  to  differences in  coating  efficiency as  both  isoforms 
bound equally well to the plastic wells (results not shown). 
Extraction of bound radiolabel and visualization by autora- 
diography  after  SDS-PAGE  shows  the  striking  binding 
preference of contactin/Fll  for tn  190 (Fig. 6 B). 
Figure  7.  Fragmentation  of 
contactin/Fll by collagenase 
digestion,  followed by  SDS- 
PAGE and silverstaining. Con- 
tactin/F11, before collagenase 
digestion  (lane  1)  and  after 
digestion  (lane  2).  Peptides 
were  freed  of contaminating 
collagenase by use of a WGA 
column  (see  Materials  and 
Methods). 
Contactin Fll Binds to Tenascin Via Its Ig-Domains 
To localize the tenascin-binding region within contactin/Fl  1, 
the six Ig-like domains were separated from the fibronectin 
type HI repeats by digestion with collagenase at a 7-amino 
acid  collagen-like  sequence  (-Gly-Pro-Pro-Gly-Pro-Pro- 
Gly-) which separates the two domains (Ranscht et al., 1988; 
Brfimmendorf  et al., 1989) (see Fig. 9 C). The digestion led 
to a  highly reproducible pattern of peptide fragments, al- 
though from their sizes it was evident that cleavage also oc- 
curred  at  additional  sites.  Contactin/Fll-fragments  were 
separated from the enzyme by affinity chromatography on 
WGA-Sepharose as described in Materials and Methods and 
analyzed by SDS-PAGE (Fig. 7, lane 2). These collagenase- 
freed fragments were labeled with 125-iodine (see Fig. 9 A, 
lane/) and tested for binding to tenascin by affinity chroma- 
tography on tenascin-Sepharose.  As  a  control, the  ~25I-la- 
beled fragments were also applied to a Sepharose 4B column 
and to a  fibronectin-Sepharose column.  Fragments bound 
exclusively to the tenascin-Sepharose column (Fig. 8 A) and 
were completely eluted with 0.5 M NaC1. No further radio- 
activity was recovered by subsequent elution with  10 mM 
EDTA and 1.5 M  NaC1.  Similar elution of the two control 
columns, Sepharose alone (data not shown) and the fibronec- 
tin-Sepharose column (Fig. 8 B), revealed no bound activ- 
ity. Although a wide range of contactin/F11 fragments were 
labeled with 125-iodine (Fig. 9 A, lane/), only fragments 
of 85, 75, and 45 kD specificity bound to the tenascin column 
(Fig.  9 A, lane 2). Bound fragments were identified by NH2- 
terminal sequencing of  the corresponding peptides of  the un- 
labeled fragment pool. Fragments were subjected to SDS- 
PAGE, electrotransferred  to a PVDF membrane, and visual- 
ized by Ponceau S-staining. As can be seen in Fig. 9 B, lanes 
2  and 3,  the 85-,  75-,  and 45-kD fragments were cleanly 
separated after SDS-PAGE. These three bands were cut out, 
and  sequenced,  revealing that the NH2-terminal sequence 
of each fragment was that of contactin/F11 itself. Some of 
the lower molecular mass  fragments,  which were labeled 
with 125-iodine but which did not bind to the tenascin col- 
umn are presumably derived from the fibronectin type Ill 
homology region of contactin/F11. However, it was difficult 
to  cleanly  separate these  on  SDS-PAGE and  only mixed 
NH2-terminal sequences were obtained after blotting onto 
PVDF membranes and sequencing, precluding a clear iden- 
tification. 
By correlation of size,  potential glycosylation, and  se- 
quence  of the  bound  fragments,  it  is  estimated  that  the 
smallest 45-kD peptide comprises the first three Ig-dornains, 
while the 75- and 85-kD peptides represent most or all the 
Ig-region (Fig. 9  C). This result shows that the three NH2- 
terminal Ig-like domains of contactin/Fll most likely con- 
tain the binding region for tenasein. 
Discussion 
We have used an affinity chromatography approach to select 
for cell surface receptors of the extraceUular matrix glyco- 
protein tenascin in chick brain. With this approach, we have 
identified contactin/Fll, a CAM on the surface of neurons, 
as a major tenascin receptor. 
Contactin/Fll  is  a  member of the immunoglobulin-like 
family of CAMs that was originally reported to be a trans- 
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Figure 8.  Affinity chromatog- 
raphy of contactin/Fl  1 peptides 
on tenascin and fibronectin col- 
umns (Tn and Fn).  125I-labeled 
fragments  of  contactin/Fll 
(see Fig. 9 A, lane 1) bound to 
the Tn  column (.4) and were 
eluted with 0.5 M  NaCI. No 
binding was  observed to  the 
control  Fn  column  (B)  and 
subsequent  washes  with  10 
mM  EDTA  or  1.5  M  NaC1 
eluted no  additional radiola- 
beled  material  from  either 
column. 
Figure  9.  Characterization  of 
tenascin binding contactin/Fll 
fragments.  (A)  Shows  the  se- 
lective binding to the tenascin 
column of 85-, 75-, and 45-kD 
fragments  (lane  2)  from  a 
125I-labeled pool  of contactin/ 
Fll  fragments  (lane  1),  de- 
tected by autoradiography after 
SDS-PAGE.  (B)  NH2-terminal 
sequencing of tenascin binding 
contactin/F1  l-fragments.  Con- 
tactin fragments (lanes 2 and 3) 
were separated by 5-15 % gra- 
dient SDS-PAGE, electrotrans- 
ferred to PVDF membrane, and 
stained with Poneeau S. Lane 1, 
high molecular mass  standard 
(SDS 7B, Sigma). The 85-, 75-, 
and 45-kD fragments were cut 
out and sequenced through their 
NH2 termini. The 85-kD frag- 
ment  began  with  amino  acid 
residues 3-9,  the  75-kD  frag- 
ment  with  residues 3-15,  and 
the 45-kD fragment with resi- 
dues 3-16 of the contactin/Fll 
amino-terminal.  (C)  A  model 
of contactin/Fll and  tenascin- 
binding  fragments  shows  that 
the binding site of  contactin/F11 
for tenasein lies within the first 
three Ig-like domains. 
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cloning of a molecule with identical extracellular domains in 
chick (FI1)  (BrOmmendorf et al.,  1989)  and mouse (F3) 
(Gennarini et al., 1989) suggested the membrane attachment 
of these latter molecules is through a GPI moiety and raised 
the possibility that contactin and Fll/F3 are isoforms of the 
same molecule containing a different membrane anchor. For 
several reasons this appears not to be the case. Firstly, the 
majority of contactin, like Fll, is released from cultured 
neurons by phosphatidyl inositol specific phospholipase C 
(PI-PLC) (B. Ranscht, unpublished data). Secondly, contac- 
tin is expressed from the corresponding eDNA in CHO and 
COS cells as a membrane protein susceptible to treatment 
with PI-PLC,  although contactin is  never completely re- 
moved from the cell surface by enzyme treatment (D. Vestal 
and B. Ranscht, manuscript in preparation). Lastly, reassess- 
ment of the contactin eDNA sequence revealed agreement 
with the data published by Briimmendorf  et al. (1989) (E. O. 
Berglund and B. Ranscht, manuscript in preparation). These 
data indicate that contactin and F11  are identical proteins 
that contain a GPI anchor. 
Solid-phase assays using immunopurified contactin/Fll 
demonstrated the binding specificity between contactin/Fll 
and tenascin and reve~ed the preferential binding of contac- 
tinlFll to the tn 190 isoform of tenascin. This implies that 
the binding site on tenascin is either disrupted or masked by 
inclusion of the alternatively spliced type RI domains. The 
masking alternative requires that an extra domain(s) in the 
220 isoform somehow folds to block the actual contactin/F11 
binding site, located in another region of tenascin. As the 
binding to tn 220 alone is almost reduced to background 
values, this would require that nearly each arm of the tn 220 
hexamer is folded into this inhibitory conformation. We ex- 
amined  rotary  shadowed  electron  micrographs  of  such 
preparations and could find no evidence to support such a 
proposal. A selective denaturation of the tn 220 isoform is 
also unlikely, as tn 220 is subjected to identical purification 
conditions as tn 190, with the only difference being that it 
is bound via the TI7 rather than the TI6 mAb, both of which 
recognize epitopes  within the fibronectin type III region 
(Kaplony et al., 1991). In addition, the alternatively spliced 
region retained its functional activity when human tenascin 
was also purified with a similar protocol to that of our own 
(see below; Murphy-Ullrich et al., 1991). For these reasons, 
we conclude that the contactin/F11 binding site is disrupted 
by the splicing-in of the additional type lII domains. This 
proposed mechanism for regulating functional activity of 
tenascin is an intriguing one and may also apply to interac- 
tions with other ligands. Fibronectin, for example, was also 
shown to bind preferentially to tn 190 (Chiquet-Ehrismann 
et al.,  1991). 
The importance of alternative splicing in the function of 
tenascin was further illustrated in another study (Murphy- 
Ullrich et al., 1991), where human tenascin, when added to 
cultures of tightly adherent endothelial cells, changed cellu- 
lar morphology by reducing the size of focal adhesions. This 
effect was reversed by monoclonal antibodies (mAb 81C6 
and  mAb  127)  which  are  specific  for different domains 
within the alternatively spliced region of human tenascin 
(Bourdon et al.,  1985;  Murphy-Ullrich et al.,  1991). This 
modulation of endothelial cell adhesion was also inhibited by 
chondroitin sulfate, implying that a cell-surface chondroitin 
sulfate proteoglycan or chondroitin sulfate-binding protein is 
involved in the destabilizing effect of tenascin on these cells. 
A neuronal chondroitin sulfate proteoglycan (CTB-proteo- 
glycan) (Hoffman and Edelman, 1987) is reported to bind to 
tenascin and thereby, at least partly, mediate neuron-glia 
adhesion. Could the neuronal contactin/F11 and the ECM, 
cytotactin binding  (CTB)  proteoglyean (or  indeed a  cell 
membrane anchored chondroitin sulfate proteoglycan) be al- 
ternative receptors for tenascin? It was recently proposed 
that an inverse gradient of chondroitin sulfate may guide 
axons during the early stages of growth along the embryonic 
retina (Brittis et al.,  1992).  As contactin/Fll and tenascin 
are also present in the retina at the time of axonal outgrowth, 
it is possible that these different molecules may combine to 
promote axon guidance. 
We have previously established that the neurite outgrowth 
promoting property of tenascin can be inhibited by a mono- 
clonal antibody (J1/tn2) which binds close to the boundary 
of the alternatively spliced region (Lochter et al.,  1991). It 
therefore seems likely that this site is the same or very close 
to the binding site on tenascin for contactin/F11. The nature 
of the neuronal receptor responsible for neurite growth on 
tenascin  was  neither  identified by  Wehrle  and  Chiquet 
(1990), nor ourselves. Curiously, the behavior of neurons on 
a  tenascin substratum is density dependent.  For neurons 
plated at high densities, fasciculation is encouraged (Kruse 
and Falssner, 1990), while neurite extension is favored at low 
cell culture densities (Lochter et al., 1991). Under the latter 
conditions the binding of the neurons, however, is restricted 
to the neurite and its growing tip, as the cell bodies do not 
adhere to tenascin but require an additional substratum such 
as polyarnines. This implies that the receptor(s) should be 
concentrated in the neurites, a distribution which matches 
the expression of contactin/F11 both in vitro and in vivo. 
Mouse contactin/Fll  (F3)  is  concentrated on neurites in 
mixed fetal brain cultures (Gennarini et al., 1989) and, like 
tenascin, can support either neurite fasciculation (Rathjen et 
al., 1987) or neurite extension (Chang et al., 1987; Gennar- 
iniet al., 1991). It will be interesting to determine whether 
the distribution of  contactin/Fll differs under conditions that 
favor neurite outgrowth or fasciculation on a tenascin sub- 
stratum, and to examine the role of contactin/Fll-tenascin 
interactions in this process. 
It is somewhat surprising that only a few examples of the 
highly versatile immunoglobulin superfamily have been re- 
ported to recognize extracellular matrix glycoproteins. This 
is especially so for the neuronal members of  this family, with 
their chimeric structures of 5-6 immunoglobulin-like do- 
mains and 2-5 fibronectin type Ifi homology domains (for 
review see Edelman and Crossin, 1991) which could poten- 
tially interact with different types of receptors.  Neuronal 
receptors of this family participate in homophilic binding, 
i.e., N-CAM and N-CAM (Curmingham et al.,  1987) and 
L1-L1 (Lemmon et al., 1989) or in heterophilic interactions 
such  as  L1-Axonin-1 (Knhn  et  al.,  1991) and  between 
N-CAM and heparan sulfate (Cole et al.,  1986).  Although 
no information is available about other neural receptors, it 
has been shown that the endothelial intercellular adhesion 
molecule ICAM-1, which is composed of five tandernly ar- 
ranged immunoglobulin-like repeats, binds via the most dis- 
tal repeat to its leukocyte integrin ligand LFA-1 (Staunton et 
al.,  1990).  Our finding that contactin/F11 binds via a site 
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to tenascin rests on the selective binding of only the NH2- 
terminal fragments to the tenascin column under the same 
conditions in which intact contactin/Fll is retained. That 
this is not an artefact of column chromatography is evident 
from the same fragments not binding to the control columns 
of  Sepharose  alone  or  fibronectin-Sepharose.  Although 
these results are unequivocal in pointing to the Ig-like region 
of contactin/F11 containing the binding site, identification of 
which domain carries this site must await further experi- 
ments, currently in progress. Nevertheless, our results are in 
agreement with published evidence for the importance of the 
distal domains of the immunoglobulin family of CAMs in 
ligand binding. 
How might contactin/F11-tenascin binding affect neuronal 
patterning in vivo? There is an overlapping distribution of  the 
two proteins in the retina (Crossin et al., 1986; Ranscht and 
Dours,  1988;  Rathjen  et  al.,  1991), in  the  cerebellum 
(Chuong et al.,  1987; Rathjen et al.,  1991; Faivre-Sarrailh 
et al., 1992; Husmann et al., 1992), and in peripheral nerves 
(Rieger et al.,  1986;  Wehrle and Chiquet,  1990;  Ranscht, 
B., 1988, unpublished data). The correlation between con- 
tactin/F11  and tenascin expression suggests that the interac- 
tion between contaetin/Fll and tenascin may affect axonal 
outgrowth or fasciculation, rather than neuronal migration. 
Consistent with a spatial separation of migration and axonal 
outgrowth promoting sites on tenascin, anti-tenascin mAbs 
blocking the migration of granule neurons in cerebrellar ex- 
plant cultures, map to a site on FN type HI homology do- 
mains 3-5  (Husmann et al.,  1992).  In contrast, the J1/tn2 
mAb, which inhibits neurite extension on tenascin in vitro 
maps close to the FN type HI domains 8,9 on chicken tenas- 
cin (Lochter et ai.,  1991) and has no inhibitory effect on 
granule cell migration (Husmarm et al., 1992). This implies 
that tenascin interacts with distinct neuronal receptors dur- 
ing neuronal migration and axon growth. During later cere- 
bellar development, contactin/Fll (F3) is specifically local- 
ized to  the  axonal extensions,  the  parallel  fibers,  of the 
granule neurons, while the granule cell bodies and dendrites 
connecting the mossy fibers are negative (Faivre-Sarrailh et 
al., 1992). As this expression pattern may indicate a role for 
contactin/Fll in establishing specific axonal connections, it 
is important to examine whether the tn 190 isoform is the 
ligand for this interaction. 
Both tenascin and contactin/Fll  interact with multiple 
ligands. In addition to tenascin, contactin/Fll binds weakly 
to itself (Fig. 3 A), to laminin (Fig. 3 A), and restrictin (Rath- 
jen et al.,  1991). Tenascin interacts with a neuronal chon- 
droitin sulfate proteoglycan (Hoffman and Edelman, 1987), 
syndecan (Salmivirta et al., 1991), collagens (Faissner et al., 
1990),  fibronectin (Chiquet-Ehrismarm et al., 1991), and a 
/3~-integrin (Bourdon and Ruoslahti,  1989).  Cell adhesion 
or repulsion is the net effect of an interplay between different 
cell-surface molecules and so it is likely that different do- 
mains within each molecule will control different cellular in- 
teractions. It would therefore be surprising if contactin/F11 
and tenascin alone controlled neuron-glia adhesion;  even 
though contactin/F11 is an exclusive component of neuronal 
cell surfaces (Ranscht and Dours, 1988),  neural tenascin is 
synthesized by glial cells (Grumet et al., 1985; Kruse et ai., 
1985, Prieto et al., 1990), and both molecules have been im- 
plicated in this interaction. The majority of contactin/Fll is 
released  from  the  cell  surface  of  cultured  neurons  by 
phosphatidylinositol-specific phospholipase C,  so that the 
availability of contactin/Fl  1 on the cell surface may be enzy- 
matically regulated. This would provide an additional mech- 
anism for the modulation of adhesive interactions between 
these cells. Having established contactin/Fll-tenascin as a 
ligand pair, it is important to turn to cellular studies to exam- 
ine under which conditions this interaction is decisive and 
to explore the interplay between these and other cell surface 
receptors. 
This  demonstration  of  tenascin-contactin/Fll  binding 
reported here presents the first indication of an interaction 
between immunoglobulin-like domains and fibronectin-type 
III repeats.  Both of these  structural elements are  widely 
spread among various CAMs and ECM-components. It will 
now be a challenge to see whether interactions between Ig- 
like domains and FN-type HI elements form a basic mecha- 
nism through which a wider range of cell-cell and cell-ma- 
trix interactions are transmitted. 
We thank Dr. Dieter Zimmermann  for helpful discussions  and critical read- 
ing of the manuscript and Rent Fischer for continued support. We also 
thank the Swiss Federal Institute of Technology Ziirich and the Swiss Na- 
tional Science Foundation for financial support. 
Barbara Ranscht is supported by grant NS 25194 from the National Insti- 
tutes of Health. 
Received for publication 1 April 1992 and in revised form 17 June 1992. 
References 
Akiyama, S. K., K. Nagata, and K. Y. Yamada. 1990.  Cell surface receptors 
for extracellular matrix components. Biochim. Biophys. Acta.  1031:91-110. 
Aufderheide, E., and P. Ekblom. 1988. Tenascin during gut development: ap- 
pearance in the mesenchyme, shift in molecular forms and dependence on 
epithelial-mesenchymal interactions. J.  Cell Biol. 107:2341-2349. 
Bartsch, S., U. Bartsch, U. DOrries,  A. Faissner, A. Weller, P. Ekblom, and 
M. Schachner. 1992. Expression of tenascin in the developing and adult cer- 
ebellar cortex. J.  Neurosci.  12:736--749. 
Bourdon, M., and E. Ruoslahti. 1989.  Tenascin mediates attachment through 
an RGD-dependent receptor. J.  Cell Biol. 108:1149-1155. 
Bourdou, M.  A., T. J.  Matthews, S. V.  Pizzo,  and D. Biguer.  1985.  Im- 
munochemical and biochemical characterization of a glioma-associated ex- 
tracellular matrix glycoprntein. ,l.  Cell Biochem.  28:183-195. 
Brittis, P. A., D. R. Canning, and J. Silver.  1992. Chondroitin sulfate as a regu- 
lator of neuronal patterning in the retina. Science (Wash. DC). 255:733-736. 
Bronner-Fraser, M. 1988. Distribution and function of tenascin during cranial 
neural crest development in the chick. J. Neurosci.  Res.  21:135-147. 
Brtimmendorf, T., J. M. Wolff, R. Frank, and F. G. Rathjen. 1989.  Neural 
cell adhesion molecule F11, homology with fibronectin type HI and immuno- 
globulin type C domains. Neuron.  2:1351-1361. 
Burgoon, M. P., M. Grumet, V. Mauro, (3. M. Edelman, and B. A. Cuaning- 
ham. 1991. Structure of  the chicken neurou-glia cell adhesion molecule, Ng- 
CAM: origin of the polypeptides and relation to the Ig superfamily. J.  Cell 
Biol.  112:1017-1029. 
Chang, S., F. G. Rathjen, and J.  A. Raper.  1987.  Extension of neurites on 
axons is impaired by antibodies against specific neural cell surface glycopro- 
teins. J.  Cell Biol. 104:355-362. 
Chiquet, M. 1989. TenascirdJ1/cytotactin: the potential function of hexabrach- 
ion proteins in neural development. Dev. Neurasci.  11:266-275. 
Chiquet,  M.,  N.  Vrucinic-Filipi,  S.  Schenk,  K.  Beck,  and  R.  Chiquet- 
Ehrismann. 1991.  Isolation of chick tenascin variants and fragments. A 
C-terminal heparin-binding fragment produced by cleavage of the extra do- 
main from the largest subunit splicing variant. Eur. J.  Biochem.  199:379- 
388. 
Chiquet-Ehiismann, R., Y. Matsuoka, U. Hofer, J. Spring, C. Bernasconi, and 
M. Chiquet. 1991. Tenascin variants: differential  binding to fibronectin and 
distinct distribution in cell cultures and tissues. Cell Regul.  2:927-938. 
Chuong, C.-M., K. L. Crossin, and G. M. Edelman. 1987. Sequential expres- 
sion and differential  function of multiple adhesion molecules during the for- 
marion of cerebellar cortical layers. J.  Cell Biol. 104:331-342. 
Cole, G. J., A. Loewy, N. V. Cross, R. Akeson, and L. Glaser. 1986. Topo- 
graphic localization of the heparin binding domain of the neural cell adhesion 
molecule N-CAM. J.  Cell Biol. 103:1739-1744. 
Crossin, K. L., S. Hoffman, M. Grumet, J.-P. Thiery, and G. M. Edelman. 
The Journal of Cell Biology, Volume 119,  1992  212 1986.  Site  restricted expression of cytotactin during development of the 
chicken embryo. J.  Cell Biol.  102:1917-1930. 
Crossin, K. L., S. Hoffman, S.-S. Tan, and G. M. Edelman. 1989. Cytotaefin 
and its proteoglyean ligand mark structural and functional boundaries in 
somatosenso  ry cortex of the early postnatal mouse. Dev. Biol.  136:381-392. 
Curminghem, B. A., J. J. Hemperly, B. A. Murray, E. A. Prediger, R. Brack- 
enbury, and G. M. Edelman. 1987. Neural cell adhesion molecule: structure, 
immunoglobulin-like  domains, cell surface modulation, and alternative RNA 
splicing. Science (Wash. DC). 236:799-806. 
Edelman, G. M., and K. Crossin. 1991. Cell adhesion molecules: implications 
for a molecular histology. Annu. Rev.  Biechem.  60:155-190. 
Erickson, H. P., and M. A. Bourdou. 1989. Tenascin: an extracellular matrix 
protein prominent in specialized embryonic tissues and tomot~. Annu. Rev. 
Cell Biol.  5:71-92. 
Erickson, H. P., and J. L. Iglesias. 1984. A six-armed oligumer isolated from 
cell surface fibronectin preparations. Nature (Lond.).  311:267-269. 
Faissner, A., and J. Kruse. 1990. Jl/tenascin is a repulsive substrate for central 
nervous system neurons. Neuron. 5:627-637. 
Falssner, A., J. Kruse, K. Kiihn, and M. Sehachner. 1990.  Binding of the Jl 
adhesion molecules to  extracellular  matrix  constituents. J.  Neurochem. 
54:1004-1015. 
Faivre-Sarrailh, C., G. Germarini, C. Goridis, and G. Rougon. 1992. F3/F11 
cell surface molecule expression  in the developing mouse  cerebellum is pola- 
rized at synaptic sites and within granule cells. J. Neurosci.  12:257-267. 
Furley, A. J., S. B. Morton, D. Manalo, D. Karagogeos, J. Dodd, and T. M. 
Jesseli. 1990. The axonal glycoprotein TAG-1 is an immunoglobulin super- 
family member with neurite outgrowth-promoting activity. Cell.  61:157- 
170. 
Germarini, G., G. Cibelli, G. Rougon, M.-G. Mattei, and C. J. Goridis. 1989. 
The mouse neuronal cell surface glycoprotein F3: a phosphatidylinositol- 
anchored member  of  the immunoglobulin  snperfamily related to chicken con- 
tactin. J.  Cell Biol.  109:775-788. 
Germa_..rini,  G., P. Durbec, A. Boned, G. Rougon, andC. Goridis. 1991. Trans- 
fected F3/F11 neuronal cell surface protein mediates intercellular adhesion 
and promotes neurite outgrowth. Neuron. 6:595--606. 
Grumet, M., S. Hoffman, K. L. Crossin, and G. M. Edelman. 1985. Cytotec- 
tin, an extracelhilar matrix protein of neural and non-neural tissue that medi- 
ates gila-neuron interaetiou. Prec. Natl. Acad.  Sci.  USA.  82:8075-8079. 
Gulcher, J. R., D. E. Nies, L. S. Marton, and K. Stefansson. 1989. An alterna- 
tively spliced region of the human  hexabrachion  contains a repeat of  potential 
glycosylation sites. Prec. Natl. Acad. Sci.  USA.  86:1588-1592. 
Hoffman, S., and G. M. Edelman. 1987. A proteoglycan with HNK-I antigenic 
determinants is a neuron-associated ligand for cytutactin. Prec. Natl. Acad. 
Sci.  USA.  84:2523-2527. 
Husmarm, K., A. Faissner, and M. Schaclmer. 1992. Tenascin promotes cere- 
bellar granule cell migration and neurite outgrowth by different domains in 
the fibroneetin type HI repeats. J.  Cell Biol.  116:1475-1486. 
Jessell, T. M. 1988.  Adhesion molecules and the hierachy of neural develop- 
merit. Neuron.  1:3-13. 
Jones, F. S., S. Hoffman, B. A. Curmingharn, and G. M. Edelman. 1989.  A 
detailed structural model ofeytotactin: protein homologies, alternative RNA 
splicing, and binding regions. Prec. Natl. Acad. Sci.  USA.  86:1905-1909. 
Kaplony, A., D. R. Zimmermarm, R. W. Fischer, B. A. lmhoff, B. F. Oder- 
matt, K. H. Winterhalter, and L. Vanghan. 1991. Teanscin Mr 220,000 iso- 
form  expression  correlates  with  corneal  cell  migration.  Development 
(Camb.).  112:605-614. 
Keynes, R., and C. Stem. 1984. Segmentation in the vertebrate nervous  system. 
Nature (Lond.).  310:786-789. 
Keynes, R., and C. Stern. 1988. Mechanisms of vertebrate segmentation. De- 
velopment (Camb.).  103:413--429. 
Kmse, J., G. Keilhauer, A. Faissner, R. Timpl, and M. Schachner. 1985. The 
Jl-glycoprotein-a  novel nervous system cell  adhesion molecule of the 
L2/HNK-1 family. Nature (Lond.).  316:146-148. 
Kulm, T. B., E. T. Stceckli, M. A. Condrau, F. G. Rathjen, and P. Sendereg- 
ger. 1991. Neurite outgrowth on immobilized axonin-1 is mediated by a het- 
erophilic interaction with LI (G4). J.  Cell Biol.  115:1113-1126. 
Laemmli, U. K. 1970.  Cleavage of structural proteins during the assembly Of 
the head of bacteriophage T4. Nature (Lond.).  227:680-685. 
Lemmon, V., K. L. Fan', and C. Lagenaner. 1989.  Ll-mediated axon out- 
growth occurs via a homophilic binding mechanism. Neuron. 2:1597-1603. 
Lochter, A., L. Vanghan, A. Kaplony, A. Prochiantz, M. Sehachner, and A. 
Falssner.  1991.  Jl/tenascin in snbstrate-bound and soluble form displays 
contrary effects on neurite outgrowth. J.  Cell Biol.  113:1159-1171. 
Mackie, E. J., R. P. Tucker, W. Halfter, R. Chiquet-Ehrismann, and H. H. 
Epperlein.  1988.  The distribution of tenascin coincides with pathways of 
neural crest cell migration. Development (Camb.).  102:237-250. 
Matsuoka,  Y.,  J.  Spring,  K.  Ballmer-Hofer,  U.  Hofer,  and  R.  Chiquet- 
Ehrismann, 1990. Differential  expression of tenascin splicing variants in the 
chick gizzard and in cell cultures. Cell Di~er. Dev. 32:417-424. 
Moos, M., R. Tacke, H. Scherer, D. Teplow, K. Frfih, and M. Schechner. 
1988.  Neural cell adhesion molecule L1 as a member of  the immunoglobulin 
superfamily with binding domains similar to that to fibronectin. Nature 
(Lond.).  334:701-703. 
Murphy-Ullrich, J. E., V. A. Lightuer, I. Aukhil, Y. Z. Yah, H. P. Ericksou, 
and M. H66k. 1991. Focal adhesion integrity is down regulated by the alter- 
natively spliced domain of human tenascin.  J.  Cell BioL  115:1127-1136. 
Nielsen, B. L., and L. R. Brown.  1984.  The basis for colored silver-protein 
complex formation in stained polyacrylamide gels. Anal  Biochem.  141: 
311-315. 
Prieto, A. L., F. S. Jones, B. A. Cunningham,  K. L. Crossin, and G. M. Edel- 
man. 1990. Localization during development of alternatively spliced forms 
of cytotactin mRNA by in situ hybridization. J.  Cell Biol.  111:685-698. 
Ranscht, B., and M. T. Dours. 1988. Sequence of contactin, a 130-kD gtyco- 
protein concentrated in areas ofinterneuronal contact, defines a new member 
of the immunoglobulin  supergene family in the nervous system. J. Cell Biol. 
107:1561-1573. 
Ranscht, B., D. J. Moss, and C. Thomas. 1984. A neuronal surface glycopro- 
rein associated with the cytoskeleton. J.  Cell Biol.  99:1803-1813. 
Rathjan, F. G., and T. M. Jessell. 1991. Glycoproteins that regulate the growth 
and guidance of vertebrate axons: domains  and dynamics  of  the immunoglob- 
ulin/fibronectin type HI subfamily. Semin,  Neurosci. 3:279-307. 
Rathjen, F. G., J, M. Wolff, and R. Chiqnet-Ehrismann. 1991.  Restrictin: a 
chick neural extracellular  matrix protein  involved in cell  attachment co- 
purifies with the cell recognition molecule FI1.  Development  (Camb). 
113:151-164. 
Reichardt, L. F., and K. J. TumaseIli. 1991. Extracellular  matrix molecules 
and their  receptors:  functions  in  neural  development. Annu. Rev.  Neurosci. 
14:531-570. 
Rieger, F., J. K. Daniloff,  M. Pinfon-Raymond, K. L. Crossin,  M. Grnmet, 
and G. M. Edelman. 1986. Neuronal cell  adhesion  molecules and cytotactin 
are colocalized  at the node of Ranvier. J. Cell  Biol. 103:379-391. 
Ruoslahti, E., E. G. Hayman,  M.  Pierschbacher, and E. Engvall. 1982. 
Fibronectin:  purification,  immunochemical properties  and biological  activi- 
ties.  Methods EnzymoL 82:803-831. 
Rutishauser,  U., and  T. M. Jessell.  1988.  Cell  adhesion  molecules in  vertebrate 
neural development. Physiol.  Res. 68:819-857. 
Salmivirta, M., K. Elenius,  S. Vainio, U. Hofer, R. Chiquet-Ehrismann, I. 
Thesloff,  and M. Jalkanen. 1991.  Syndecan from embryonic rnesenchyme 
binds tenascin..I.  Biol. Chem. 266:7733-7739. 
Spring,  J.,  K. Beck, and  R. Chiquet-Ehrismann. 1989. Two contrary  functions 
of  tenascin:  dissection  of  the  active  sites  by recombinant tenascin  fragments. 
Cell. 59:325-334. 
Staunton, D. E., M. L. Dustin, H. P. Erickson, and T. Springer. 1990.  The 
arrangement of  the  immunoglohulin-like domains of  ICAM-I and the  bind- 
ing sites  for LFA-I and rhinovirus.  Cell.  61:243-254. 
Steindler, D. A., N. G. F. Cooper, A. Faissner,  and M. Schachner. 1989. 
Boundaries defined by adhesion molecules during development of the cere- 
bral cortex: the Jl/tenascin glycoprotein in the mouse somatosensory  cortical 
barrel field. Dev. Biol.  131:248-260. 
Stem, C. D., W. E. Norris, M. Bronner-Fraser, G. J. Carlson, A. Faissner, 
and M. Schachner. 1989. Jl/tenasein-related molecules are not responsible 
for the segmented pattern of neural crest cells or motor axons in the chick 
embryo. Development (Camb.).  107:309-319. 
Stoeckli, E. T., T. B. Kuhn, C. O. Due, M. A. Ruegg, and P. Sonderegger. 
1991. The axonally secreted protein axonin-I is a potent substratum for neu- 
rite growth. J.  Cell Biol.  112:449--455. 
Tan, S.-S., K. L. Crossin, S. Hoflinan, and G. M. Edelman. 1987. Asymmetric 
expression in somites of eytotactin and its proteoglycan ligand is correlated 
with neural crest cell distribution. Proc. Natl. Acad.  Sci.  USA.  84:7977- 
7981. 
Tan, S.-S., A. Prieto, D. F. Newgreen, K. L. Crossin, and G. M. Edelman. 
1991. Cytotactin expression in somites after dorsal tube and neural crest ab- 
lation in chicken embyos. Prec. Natl. Acad.  Sci.  USA.  88:6398-6402. 
Vaughan, L., S, Huber, M. Chiquet, and K. H. Winterhalter. 1987.  A major 
six-armed glycoprotein from embryonic cartilage. EMBO (Eur. Mol.  Biol. 
Organ.) J.  6:349-353. 
Wehrle, B., and M. Chiquet. 1990. Tenascin is accumulated along developing 
peripheral  nerves  and  allows  neurite  outgrowth  in  vitro.  Development 
(Camb.).  110:401-415. 
Weller, A., S. Beck, and P. Ekblom.  1991.  Amino acid sequence of mouse 
tenascin and differential expression of two tenascin isoforms during embryo- 
genesis. J.  Cell Biol.  112:355-362. 
Zisch et al. Contactin/Fll Is a Neuronal Tenascin  Receptor  213 